GOSS · NASDAQ · Biotechnology

Gossamer Bio (GOSS)

Develops inhaled seralutinib for pulmonary arterial hypertension and PH-ILD.

$11.71
After-hours close−0.09 (−0.76%)
At close$11.80(+4.61%)